Eleven Biotherapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Eleven Biotherapeutics Inc
CIK #0001485003
EDGAR Form CIK 2011 - 2026
10-K [0001485003]
10-Q [0001485003]
3 [0001485003]
4 [0001485003]
8-K [0001485003]
D [0001485003]
SC 13D [0001485003]
SC 13G [0001485003]
Form 13D/13G Filer Form 13D/13G Subject Filed
AbbVie Biotechnology Ltd Carisma Therapeutics Inc [2024-03-13]
Trustees of the University of Pennsylvania Carisma Therapeutics Inc [2023-03-17]
Longview Innovation Corp Carisma Therapeutics Inc [2023-03-16]
Modernatx Inc Carisma Therapeutics Inc [2023-03-13]
HealthCap VII LP Carisma Therapeutics Inc [2023-03-09]
Radoff Bradley Louis Sesen Bio Inc [2022-11-18]
BlackRock Inc Sesen Bio Inc [2022-07-08]
Vanguard Group Inc Sesen Bio Inc [2022-02-10]
BlackRock Inc Sesen Bio Inc [2022-02-04]
Integrated Assets II LLC Sesen Bio Inc [2021-06-28]
View All
Form 3/4/5 Subject 2011 - 2026
Carisma Therapeutics Inc
Klichinsky Michael
Kelly Steven
McAndrew Natalie
Cheng Sohanya Roshan
Scadden David
Thorell Marella
Morrison Briggs
Zweifach Sanford S
Hohneker John
Torok Michael
Morris Richard Steven
Ugwumba Chidozie
ModernaTX Inc
Odlander Bjorn
Hodits Regina
Ryu Elly
MacDonald Glen C
Sullivan Mark
Forbes Monica
Cannell Thomas R
Duker Jay S
Honig Peter
Jewett Michael A S
Keyes Jason A
Bourdow Carrie L
Rosales Minori
Drake Patricia M
Henderson Jane
Anderson Kirstin
Dixon Wendy L
Dan Leslie
Lynch Daniel
Fitzgerald Richard F
Kim Dennis
Chaney Paul G
Celniker Abbie
Hurly Stephen A
Gertz Barry
McCabe John J
DeCillis Arthur
Clairmark Investments Ltd
Flagship Ventures 2007 General Partner LLC
Flagship Ventures Fund IV LP
Flagship Ventures Fund IV General Partner LLC
Afeyan Noubar
Flagship Ventures Fund 2007 LP
Kania Edwin
Flagship Ventures Fund IV-RX LP
Tubridy Karen L
Lewis Joseph
MVA Investors LLC
Boxer Asset Management Inc
Boxer Capital LLC
Pfeffer Cary
Berry David A
Furfine Eric Steven
JAFCO Super V3 Investment Limited Partnership
Perry Gregory D
Levin Mark J
TRV GP LLC
Third Rock Ventures LP
Starr Kevin P
Tepper Robert I
Third Rock Ventures GP LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Carisma Therapeutics Inc CARM
Common Stock
2025-10-07 Option exercise 56,982 $0.11 6,268
Carisma Therapeutics Inc CARM
Common Stock
2025-10-07 Sell 56,982 $0.25 14,246
Carisma Therapeutics Inc CARM
Stock Option (right to buy) · derivative
2025-10-07 Option exercise 56,982 $0.00
Carisma Therapeutics Inc CARM
Common Stock
2025-10-03 Sell 119,347 $0.26 31,030
Carisma Therapeutics Inc CARM
Common Stock
2025-10-02 Sell 200,000 $0.25 50,000
Carisma Therapeutics Inc CARM
Common Stock
2025-10-01 Sell 165,000 $0.26 42,900
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2025-01-28 Grant 500,000 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2025-01-28 Grant 221,000 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-10-31 Grant 38,700 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-07-01 Grant 38,700 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-07-01 Grant 38,700 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-26 Grant 19,350 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-26 Grant 19,350 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-26 Grant 19,350 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-26 Grant 19,350 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-17 Grant 85,000 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-17 Grant 85,000 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-17 Grant 125,000 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-04-01 Grant 38,700 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-01-31 Grant 170,500 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com